# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA3741292 | 27 | Ki | = | 2845.2 | nM | ALA3744552 | 5.55 | nM | Cavia porcellus | ||
2. | ALA3740256 | 26 | Ki | = | 43.6 | nM | ALA3744552 | 7.36 | nM | Cavia porcellus | ||
3. | Risperidone | Risperidone | Ki | = | 41.2 | nM | ALA3744552 | 7.38 | nM | Cavia porcellus | ||
4. | ALA42 | clozapine | Ki | = | 8.1 | nM | ALA3744552 | 8.09 | nM | Cavia porcellus | ||
5. | Risperidone | Risperidone | Ki | = | 38.3 | nM | ALA3635894 | 7.42 | nM | Cavia porcellus | ||
6. | ALA42 | clozapine | Ki | = | 12.2 | nM | ALA3635894 | 7.91 | nM | Cavia porcellus | ||
7. | ALA3634821 | 29 | Ki | = | 3153 | nM | ALA3635894 | 5.50 | nM | Cavia porcellus | ||
8. | ALA3634813 | 21 | Ki | = | 54.2 | nM | ALA3635894 | 7.27 | nM | Cavia porcellus | ||
9. | mepyramine | Mepyramine | pA2 | = | 8.84 | ALA3405830 | 8.84 | nM | Cavia porcellus | |||
10. | ALA3402827 | 16 | pA2 | = | 6.5 | ALA3405830 | 6.50 | nM | Cavia porcellus | |||
11. | JZP 361 | 12a, JZP-361 | pA2 | = | 6.81 | ALA3405830 | 6.81 | nM | Cavia porcellus | |||
12. | Loratadine Epoxide | loratadine | pA2 | = | 7.14 | ALA3405830 | 7.14 | nM | Cavia porcellus | |||
13. | Sigma-1 receptor antagonist 1 | 137 | INH | < | 50 | % | ALA3385470 | % | Cavia porcellus | |||
14. | ALA4162433 | 10 | pKb | = | 6.15 | ALA4154397 | Cavia porcellus | |||||
15. | Argireline | Antistine | pA2 | = | 7.14 | ALA4154395 | 7.14 | nM | Cavia porcellus | |||
16. | ALA4162433 | 10 | INH | 0 | ALA4154395 | Dose-dependent effect | % | Cavia porcellus | ||||
17. | ALA4162433 | 10 | Activity | 0 | ALA4154393 | Not Active | Cavia porcellus | |||||
18. | Argireline | Antistine | pA2 | = | 7.14 | ALA4122102 | 7.14 | nM | Cavia porcellus | |||
19. | ALA4129589 | 11 | pA2 | = | 6.15 | ALA4122101 | 6.15 | nM | Cavia porcellus | |||
20. | ALA4126145 | 13 | pKb | = | 5.91 | ALA4122099 | Cavia porcellus |